Imfinzi

DRUG2 trials

Sponsors

University Medical Center Groningen, AstraZeneca

Conditions

Carcinoma, Non-Small-Cell LungLocally Advanced Rectal Carcinoma

Phase 1

Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy

Not yet recruitingNCT06304597

University Medical Center GroningenLocally Advanced Rectal Carcinoma

Start: 2024-04-01End: 2025-06-01Target: 18Updated: 2024-03-12

Unknown Phase

A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC

Not yet recruitingNCT07760519

AstraZenecaCarcinoma, Non-Small-Cell Lung

Start: 2026-09-30End: 2030-04-30Target: 78Updated: 2026-08-12